Melius Affirms Hold on NVIDIA

Analyst: Ben Reitzes 1 min read Reproduced verbatim
Rating
Hold
Unchanged
Target
N/A
No target in this note
Upside
N/A
No target to measure

Melius Research’s latest target on NVIDIA is now $185 (Nov 12, 2026); the median of 33 firms is $230.

Melius Research and NVIDIA logos

What the analyst said

Melius Research analyst Ben Reitzes reiterated a Hold rating on NVIDIA (NASDAQ: NVDA).

“We don’t think Nvidia benefits from raising guidance tomorrow given all the unknowns.”

“Buckle-up for what could be the most important conference call of our careers.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Track record

Firm track recordMelius Research: 70% of its 10 targets at least a year old were reached within 12 months; on NVIDIA, 1 of 3. Accuracy ranking →

Melius Research on NVIDIA

Melius Research price targets on NVIDIA

6 calls from November 20, 2025 to November 16, 2026. The target went from $320 to $185 (−42%). The rating moved from Buy to Hold.

Melius Research targetNVDA share price
  1. November 16, 2026 This noteRating only, no price targetHoldNo target
  2. November 12, 2026Downgraded to Hold, target cut from $420 (−56%)Hold$185
  3. August 27, 2026Target raised from $400 (+5%)Buy$420
  4. May 21, 2026Target raised from $350 (+14%)Buy$400
  5. January 5, 2026Target raised from $320 (+9%)Buy$350
  6. November 20, 2025Earliest call shownBuy$320
Share Reddit StockTwits
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.